Skip to main content

Advertisement

SpringerLink
Log in

Stereotactic biopsy combined with stereotactic 125iodine brachytherapy for diagnosis and treatment of locally recurrent single brain metastases

  • Clinical Study – Patient Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

This paper reports on stereotactic biopsy combined with stereotactic 125iodine brachytherapy (SBT) for locally recurrent, previously irradiated cerebral metastases, focusing on feasibility, complications, cerebral disease control, and survival. All patients with suspected locally recurrent metastases detected by MRI were selected for this combined procedure. After stereotactic biopsy, all patients with a verified vital tumor underwent SBT (50 Gy surface dose applied for 42 days) during the same surgical procedure. Histological results of biopsy, complications, treatment response, local and distant disease control, and survival were evaluated. Thirty patients underwent stereotactic biopsy, and 27 were treated with SBT for histologically proved tumor recurrence. There was no treatment-related mortality, and morbidity was transient and low (6.6%). Median survival was 14.8 months. After one year the actuarial incidence of local and distant relapse was 6.7 and 45.5%, respectively. There was no grade 3 or 4 CNS toxicity, even among the 18.5% of patients with tumors >30 mm. For these patients stereotactic biopsy seems to be a safe and valuable means of differentiating between radiation-induced tissue changes and tumor recurrence/progression. SBT is a safe, minimally invasive, and highly effective treatment option for cerebral disease control and survival. Furthermore, it can be performed during the same stereotactic operation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ammirati M, Cobbs CS, Linskey ME, Paleologos NA, Ryken TC, Burri SH, Asher AL, Loeffler JS, Robinson PD, Andrews DW, Gaspar LE, Kondziolka D, McDermott M, Mehta MP, Mikkelsen T, Olson JJ, Patchell RA, Kalkanis SN (2010) The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:85–96

    Article  PubMed  Google Scholar 

  2. Hoffman R, Sneed PK, McDermott MW, Chang S, Lamborn KR, Park E, Wara WM, Larson DA (2001) Radiosurgery for brain metastases from primary lung carcinoma. Cancer J 7:121–131

    PubMed  CAS  Google Scholar 

  3. Wong WW, Schild SE, Sawyer TE, Shaw EG (1996) Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys 34:585–590

    Article  PubMed  CAS  Google Scholar 

  4. Truong MT, St Clair EG, Donahue BR, Rush SC, Miller DC, Formenti SC, Knopp EA, Han K, Golfinos JG (2006) Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery. Neurosurgery 59:86–97 (discussion 86–97)

    Article  PubMed  Google Scholar 

  5. Noel G, Medioni J, Valery CA, Boisserie G, Simon JM, Cornu P, Hasboun D, Ledu D, Tep B, Delattre JY, Marsault C, Baillet F, Mazeron JJ (2003) Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. Lung Cancer 41:333–343

    Article  PubMed  Google Scholar 

  6. Peterson AM, Meltzer CC, Evanson EJ, Flickinger JC, Kondziolka D (1999) MR imaging response of brain metastases after gamma knife stereotactic radiosurgery. Radiology 211:807–814

    PubMed  CAS  Google Scholar 

  7. Plowman PN (1999) Stereotactic radiosurgery. VIII. The classification of postradiation reactions. Br J Neurosurg 13:256–264

    Article  PubMed  CAS  Google Scholar 

  8. Huber PE, Hawighorst H, Fuss M, van Kaick G, Wannenmacher MF, Debus J (2001) Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 49:1339–1349

    Article  PubMed  CAS  Google Scholar 

  9. Hoefnagels FW, Lagerwaard FJ, Sanchez E, Haasbeek CJ, Knol DL, Slotman BJ, Vandertop WP (2009) Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. J Neurol 256:878–887

    Article  PubMed  Google Scholar 

  10. Voges J, Treuer H, Sturm V, Buchner C, Lehrke R, Kocher M, Staar S, Kuchta J, Muller RP (1996) Risk analysis of linear accelerator radiosurgery. Int J Radiat Oncol Biol Phys 36:1055–1063

    Article  PubMed  CAS  Google Scholar 

  11. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47:291–298

    Article  PubMed  CAS  Google Scholar 

  12. Shaw E, Scott C, Souhami L, Dinapoli R, Bahary JP, Kline R, Wharam M, Schultz C, Davey P, Loeffler J, Del Rowe J, Marks L, Fisher B, Shin K (1996) Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). Int J Radiat Oncol Biol Phys 34:647–654

    Article  PubMed  CAS  Google Scholar 

  13. Maldaun MV, Aguiar PH, Lang F, Suki D, Wildrick D, Sawaya R (2008) Radiosurgery in the treatment of brain metastases: critical review regarding complications. Neurosurg Rev 31:1–8 (discussion 8–9)

    Article  PubMed  Google Scholar 

  14. Prados M, Leibel S, Barnett CM, Gutin P (1989) Interstitial brachytherapy for metastatic brain tumors. Cancer 63:657–660

    Article  PubMed  CAS  Google Scholar 

  15. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277–1280

    PubMed  CAS  Google Scholar 

  16. Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205

    Google Scholar 

  17. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500

    Article  PubMed  CAS  Google Scholar 

  18. Ruge MI, Suchorska B, Maarouf M, Runge M, Treuer H, Voges JV, Sturm V (2011) Stereotactic 125Iodine brachytherapy for the treatment of singular brain metastases. Closing a gap? Neurosurgery. doi:10.1227/NEU.0b013e31820b526a

  19. Ruge MI, Kocher M, Maarouf M, Hamisch C, Treuer H, Voges J, Sturm V (2011) Comparison of stereotactic brachytherapy (125Iodine seeds) with stereotactic radiosurgery (LINAC) for the treatment of singular cerebral metastases. Strahlenther Onkol 187(1):7–14

    Google Scholar 

  20. Sturm V, Pastyr O, Schlegel W, Scharfenberg H, Zabel HJ, Netzeband G, Schabbert S, Berberich W (1983) Stereotactic computer tomography with a modified Riechert–Mundinger device as the basis for integrated stereotactic neuroradiological investigations. Acta Neurochir (Wien) 68:11–17

    Article  CAS  Google Scholar 

  21. Treuer H, Klein D, Maarouf M, Lehrke R, Voges J, Sturm V (2005) Accuracy and conformity of stereotactically guided interstitial brain tumour therapy using I-125 seeds. Radiother Oncol 77:202–209

    Article  PubMed  Google Scholar 

  22. Voges J, Sturm VV (1999) Interstitial irradiation with stereotactically implanted I-125 seeds for the treatment of cerebral glioma. Crit Rev Neurosurg 9:223–233

    Article  PubMed  Google Scholar 

  23. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485–1489

    Article  PubMed  CAS  Google Scholar 

  24. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672

    Article  PubMed  Google Scholar 

  25. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491

    Article  PubMed  CAS  Google Scholar 

  26. Muacevic A, Wowra B, Siefert A, Tonn JC, Steiger HJ, Kreth FW (2008) Microsurgery plus whole brain irradiation versus gamma knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 87:299–307

    Article  PubMed  Google Scholar 

  27. Ross DA, Sandler HM, Balter JM, Hayman JA, Archer PG, Auer DL (2002) Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. J Neurooncol 56:175–181

    Article  PubMed  Google Scholar 

  28. Henry RG, Vigneron DB, Fischbein NJ, Grant PE, Day MR, Noworolski SM, Star-Lack JM, Wald LL, Dillon WP, Chang SM, Nelson SJ (2000) Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 21:357–366

    PubMed  CAS  Google Scholar 

  29. Chao ST, Suh JH, Raja S, Lee SY, Barnett G (2001) The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 96:191–197

    Article  PubMed  CAS  Google Scholar 

  30. Serizawa T, Saeki N, Higuchi Y, Ono J, Matsuda S, Sato M, Yanagisawa M, Iuchi T, Nagano O, Yamaura A (2005) Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after gamma knife surgery for metastatic brain tumors. J Neurosurg 102(Suppl):266–271

    Article  PubMed  Google Scholar 

  31. Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, Liang L, Ushio Y, Takahashi M (2000) Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 21:901–909

    PubMed  CAS  Google Scholar 

  32. Kreth FW, Muacevic A, Medele R, Bise K, Meyer T, Reulen HJ (2001) The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours—a prospective study. Acta Neurochir (Wien) 143:539–545 (discussion 536–545)

    Article  CAS  Google Scholar 

  33. Heper AO, Erden E, Savas A, Ceyhan K, Erden I, Akyar S, Kanpolat Y (2005) An analysis of stereotactic biopsy of brain tumors and nonneoplastic lesions: a prospective clinicopathologic study. Surg Neurol 64(Suppl 2):S82–S88

    Article  PubMed  Google Scholar 

  34. Ostertag CB, Kreth FW (1995) Interstitial iodine-125 radiosurgery for cerebral metastases. Br J Neurosurg 9:593–603

    Article  PubMed  CAS  Google Scholar 

  35. Schulder M, Black PM, Shrieve DC, Alexander E III, Loeffler JS (1997) Permanent low-activity iodine-125 implants for cerebral metastases. J Neurooncol 33:213–221

    Article  PubMed  CAS  Google Scholar 

  36. Huang K, Sneed PK, Kunwar S, Kragten A, Larson DA, Berger MS, Chan A, Pouliot J, McDermott MW (2009) Surgical resection and permanent iodine-125 brachytherapy for brain metastases. J Neurooncol 91:83–93

    Article  PubMed  CAS  Google Scholar 

  37. Petr MJ, McPherson CM, Breneman JC, Warnick RE (2009) Management of newly diagnosed single brain metastasis with surgical resection and permanent I-125 seeds without upfront whole brain radiotherapy. J Neurooncol 92:393–400

    Article  PubMed  Google Scholar 

  38. Ostertag CB, Warnke P, Kleihues P, Bigner DD (1984) Iodine-125 interstitial irradiation of virally induced dog brain tumours. Neurol Res 6:176–180

    PubMed  CAS  Google Scholar 

  39. Schnell O, Scholler K, Ruge M, Siefert A, Tonn JC, Kreth FW (2008) Surgical resection plus stereotactic 125I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma—feasibility and outcome of a combined local treatment concept. J Neurol 255:1495–1502

    Article  PubMed  CAS  Google Scholar 

  40. Voges J, Treuer H, Schlegel W, Pastyr O, Sturm V (1993) Interstitial irradiation of cerebral gliomas with stereotactically implanted iodine-125 seeds. Acta Neurochir Suppl (Wien) 58:108–111

    CAS  Google Scholar 

  41. Kreth FW, Faist M, Grau S, Ostertag CB (2006) Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors. Cancer 106:1372–1381

    Article  PubMed  Google Scholar 

  42. Kreth FW, Faist M, Warnke PC, Rossner R, Volk B, Ostertag CB (1995) Interstitial radiosurgery of low-grade gliomas. J Neurosurg 82:418–429

    Article  PubMed  CAS  Google Scholar 

  43. Korinthenberg R, Neuburger D, Trippel M, Ostertag C, Nikkhah G (2011) Long-term results of brachytherapy with temporary Iodine-125 seeds in children with low-grade gliomas. Int J Radiat Oncol Biol Phys 79(4):1131–1138

    Google Scholar 

Download references

Conflict of interest statement

None of the authors has any financial or personal relationships with other people or organizations that inappropriately influenced this work. The development of this manuscript was supported in part by the Jörg-Bernards Foundation, Cologne, Germany.

Author information

Authors and Affiliations

  1. Department of Stereotactic and Functional Neurosurgery, University Hospital of Cologne, Kerpener Straße 62, 50937, Cologne, Germany

    Maximilian I. Ruge, Philipp Kickingereder, Mauritius Hoevels, Harald Treuer & Volker Sturm

  2. Department of Neurosurgery, University Hospital of Cologne, Cologne, Germany

    Stefan Grau

Authors
  1. Maximilian I. Ruge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philipp Kickingereder
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefan Grau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mauritius Hoevels
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Harald Treuer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Volker Sturm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maximilian I. Ruge.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruge, M.I., Kickingereder, P., Grau, S. et al. Stereotactic biopsy combined with stereotactic 125iodine brachytherapy for diagnosis and treatment of locally recurrent single brain metastases. J Neurooncol 105, 109–118 (2011). https://doi.org/10.1007/s11060-011-0571-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-011-0571-z

Keywords

Search

Navigation